The radiopharmaceutical 123I-metaiodobenzylguanidine (MIBG) was approved by the Food
and Drug Administration in March 2013 for the assessment of myocardial sympathetic …

Abstract 123Iodine-meta-iodobenzylguanidine (123I-MIBG) imaging can visualize cardiac
sympathetic innervation by providing (semi-) quantitative information on the myocardial …

Imaging of cardiac sympathetic innervation is only possible by nuclear cardiology
techniques and its assessment is key in the evaluation of and decision-making for patients …

The 123-I radiolabelled metaidobenzyguanidine (MIBG) is a norepinephrine analogue used
for the functional assessment of the sympathetic nerve terminals of the heart. Planar …

The 123I-labeled meta-iodobenzylguanidine (MIBG) is an analogue of noradrenaline that
can evaluate cardiac sympathetic activity in scintigraphy. Quantitative analysis of 123I-MIBG …

This proposal for standardization of 123 I-metaiodobenzylguanidine (iobenguane, MIBG)
cardiac sympathetic imaging includes recommendations for patient information and …

The autonomic nervous system plays an important role in the human heart. Activation of the
cardiac sympathetic nerve system is a cardinal pathophysiological abnormality associated …

Cardiac sympathetic neuronal function and activity can be assessed noninvasively by the
use of 123I-metaiodobenzylguanidine (123I-MIBG), an analogue of norepinephrine [1]. In …

Purpose Myocardial sympathetic imaging with 123 I-meta-iodobenzylguanidine (123 Im IBG)
has gained clinical momentum. Although the need for standardization of 123 Im IBG …

Cardiac autonomic innervation plays a key role in maintaining hemodynamic and
electrophysiologic harmony. Cardiac sympathetic function is adversely altered in many …